Tokai Tokyo Investment Co., Ltd.
Tokyo, Tokyotokaitokyo-fh.jp
Overview
Tokai Tokyo Investment Co., Ltd. is the venture capital subsidiary of Tokai Tokyo Financial Holdings, a Japanese financial services group. Established in 2006, the firm engages in venture capital activities and fund management, with a focus on investing in and cultivating venture companies, primarily within Japan's Tokai region.
Portfolio Companies
13
Website
tokaitokyo-fh.jpInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Metagen Therapeutics, Inc. | Feb 2026 | Series B | Co-investor |
| Surv BioPharma Inc. | Nov 2025 | Series B | Co-investor |
| Helical Fusion Co., Ltd. | Jul 2025 | Series A | Co-investor |
| J-Pharma | Apr 2025 | Series E Extension | Co-investor |
| Melody International Ltd. | Nov 2023 | VC Round | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
